Intensive research for the best therapeutic approaches
Research and support: For WÖRWAG Pharma it is an essential part of the company culture that we invest in innovative therapeutic approaches.
More and more people are suffering from diabetes worldwide, with a rising trend. Projections estimate that by 2030 well over 400 million people will suffer from diabetes. The causes of diabetes mellitus are clear: obesity, lack of exercise and poor diet lead via insulin resistance to low insulin and increasing blood-sugar levels.
Research at WÖRWAG Pharma concentrates on the effects of the disease, such as diabetic nerve disorders. International clinical studies, expert meetings and symposia, along with close collaboration with research laboratories: we commit ourselves scientifically in order to obtain the best possible therapeutic approaches for our patients.
How important the products of WÖRWAG Pharma are in the use of the therapy of diabetics an its accompanying disorders is shown by current research: for example benfotiamine with its high bio-availability and its major protective functions is here an important device.
Alongside the nerve protection proven by clinical studies, there is the prospect of all-inclusive blood-vessel and organ protection for diabetics - a broad field of research, in which WÖRWAG Pharma is intensively involved. So that physicians, pharmacists and patients can continue to rely on effective medication of the highest quality.